Skip to main content Back to Top

ASHP Policy Position 0720

STANDARDIZING PREFIXES AND SUFFIXES IN DRUG PRODUCT NAMES

Status: Current

To collaborate with others, including the United States Pharmacopeia and the Food and Drug Administration, in standardizing and defining the meaning of prefixes and suffixes for prescription and nonprescription drugs to prevent medication errors and ensure patient safety.

This policy was reviewed in 2022 by the Council on Public Policy and was found to still be appropriate.

Rationale

This policy position was developed before preparation of a policy rationale became routine, so no rationale is available.